|
| |
| | 47102 | | 14.06.1985 | | Pfizer AG | | 01.07.2005 | | | | | | | | | | 01.04.10. | | | | 01.04.10. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
03 | Temesta Expidet 1 mg | Lyophilisat zum Einnehmen | Soluble Powder (Lorazepam 1 mg) | N05BA06 | CI | 04 | Temesta Expidet 2.5 mg | Lyophilisat zum Einnehmen | Soluble Powder (Lorazepam 2.5 mg) | N05BA06 | CI |
|
|
|